Your session is about to expire
← Back to Search
Targeted Radiation Therapy for Breast Cancer (Second Chance Trial)
Second Chance Trial Summary
This trial is testing a new way to give radiation therapy that may help women who have had a breast recurrence after a lumpectomy.
Second Chance Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSecond Chance Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Second Chance Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have up to 3 lymph nodes with cancer but no spread beyond their capsule.I have had targeted radiation therapy for breast cancer.My cancer has not spread to distant parts of my body.I am 18 years old or older.I am unhappy with how my previous surgery and radiation therapy look.My breast cancer has a large area of growth within the milk ducts.My cancer has spread to other parts of my body.My cancer has come back in the area near where it first started.I have a single breast tumor on one side.It has been over a year since my initial breast cancer treatment and the cancer has come back.I have been diagnosed with breast cancer.My tumor is smaller than 3 cm and does not affect the skin.I can receive any type of systemic therapy.
- Group 1: Radiation Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current sample size of this medical research?
"Affirmative. Clinicaltrials.gov reports that this clinical trial is actively seeking enrolment, having first gone live on June 30th 2020 and updated for the last time on July 29th 2022. The study needs to enroll 60 patients from 3 distinct sites in order to complete its objectives."
What are the dangers associated with administering this treatment to patients?
"Our experts at Power rated this treatment's safety, on a scale of 1 to 3, as 2. This is due to the fact that only Phase 2 trial data exists for the drug, and it shows some evidence of safety features but none concerning its efficacy."
Is enrollment for this experiment currently taking place?
"Affirmative. As of July 29th 2022, clinicaltrials.gov data shows that this medical trial is still seeking participants. It was initially posted on June 30th 2020 and seeks to enlist 60 individuals from 3 different sites."
Am I eligible to join the research project?
"For this clinical trial, 60 individuals with breast cancer between the ages of 19 and 90 are being admitted. In addition to meeting these age requirements, participants must have had at least 12 months since their initial breast conserving treatment (surgery plus radiotherapy) before recurrence; be devoid of synchronous distant metastases; possess an isolated ipsilateral unifocal lesion that is under 2-3 cm in size without skin involvement; and present technical feasibility."
Is this trial open to those under 85 years of age?
"This trial only enrolls patients aged 19 to 90. Conversely, for those younger than 18 and older than 65 there are 52 studies and 1334 studies respectively available."
Share this study with friends
Copy Link
Messenger